youtube_live
Q3 2026 earnings • in 5 days
See detailschevron_right
GH:NASDAQ
Guardant Health Inc
$178.80
arrow_downward
-3.51%(-6.51) 1D
$178.00
arrow_downward
-0.45% (-0.80)bedtimeAfter hours
Closed: Oct 30, 3:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$182.48
High
$185.64
Low
$175.44
Mkt. cap
23.99B
Avg. vol.
1.86M
Volume
1.50M
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$182.48
High
$185.64
Low
$175.44
Mkt. cap
23.99B
Avg. vol.
1.86M
Volume
1.50M
52-wk high
$191.01
52-wk low
$74.55
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com
Analyst ratings
Based on 18 analysts giving stock ratings to GH in the past 3 months
Strong buy
Buy
18
Hold
0
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for GH in the last 3 months.
Highest
Current $178.80
$225.00 (+25.84%)
Average
$203.81 (+13.99%)
Lowest
$180.00 (+0.67%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Mark Massaro BTIG | Buy | Maintained | $210.00 | +17.4% | 10/27/2026 |
Max Masucci Roth MKM | Buy | Initiated | $200.00 | +11.9% | 10/22/2026 |
Kallum Titchmarsh Morgan Stanley | Buy | Maintained | $200.00 | +11.9% | 10/20/2026 |
Eve Burstein Bernstein | Buy | Reiterated | $210.00 | +17.4% | 10/19/2026 |
Casey Woodring J.P. Morgan | Buy | Maintained | $195.00 | +9.1% | 10/14/2026 |
Lu Li Bank of America Securities | Buy | Maintained | $200.00 | +11.9% | 10/09/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | $200.00 | +11.9% | 10/09/2026 |
Luke Sergott Barclays | Buy | Maintained | $220.00 | +23% | 10/07/2026 |
Subbu Nambi Guggenheim | Buy | Maintained | $200.00 | +11.9% | 10/01/2026 |
Evie Koslosky Goldman Sachs | Buy | Maintained | $225.00 | +25.8% | 09/20/2026 |
William Bonello Craig-Hallum | Buy | Maintained | - | - | 09/15/2026 |
David Westenberg Piper Sandler | Buy | Maintained | $193.00 | +7.9% | 09/15/2026 |
Unknown Analyst UBS | Buy | Maintained | $225.00 | +25.8% | 09/09/2026 |
Doug Schenkel UBS | Buy | Maintained | $225.00 | +25.8% | 09/09/2026 |
Jamie Clark Rothschild & Co Redburn | Buy | Initiated | $203.00 | +13.5% | 09/08/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 09/08/2026 |
Bradley Bowers Mizuho Securities | Buy | Maintained | $200.00 | +11.9% | 08/04/2026 |
Mason Carrico Stephens | Buy | Maintained | $195.00 | +9.1% | 08/04/2026 |
Kyle Mikson CFA Canaccord Genuity | Buy | Maintained | $205.00 | +14.7% | 08/02/2026 |
Daniel Arias Stifel Nicolaus | Buy | Maintained | $180.00 | +0.7% | 08/03/2026 |
Dan Leonard RBC Capital | Buy | Reiterated | $200.00 | +11.9% | 07/31/2026 |
Daniel Brennan TD Cowen | Buy | Reiterated | $210.00 | +17.4% | 07/31/2026 |
Brandon Couillard Wells Fargo | Buy | Maintained | $125.00 | -30.1% | 07/29/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $215.00 | +20.2% | 07/08/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $200.00 | +11.9% | 07/06/2026 |
Puneet Souda Leerink Partners | Buy | Reiterated | - | - | 06/02/2026 |
Paige Chamberlain Wolfe Research | Buy | Reiterated | $150.00 | -16.1% | 06/01/2026 |
Unknown Analyst Wolfe Research | Buy | Reiterated | $150.00 | -16.1% | 06/01/2026 |
Andrew Brackmann William Blair | Buy | Maintained | - | - | 05/27/2026 |
Catherine Ramsey Schulte Robert W. Baird | Buy | Maintained | $129.00 | -27.9% | 05/08/2026 |
Andrew Cooper Raymond James | Buy | Reiterated | $129.00 | -27.9% | 02/23/2026 |
Next call in 5 days
Thu, Nov 5, 11:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.31
Revenue / Est. (USD)
- / 350.64M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 265.20M | 281.27M | 301.66M | 334.98M |
Cost of goods sold | 93.59M | 99.49M | 104.92M | 115.95M |
Cost of revenue | 93.59M | 99.49M | 104.92M | 115.95M |
Research and development expenses | 89.96M | 98.26M | 91.04M | 96.53M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 180.53M | 204.20M | 227.06M | 250.61M |
Operating expense | 270.48M | 302.46M | 318.10M | 347.15M |
Total operating expenses | 364.07M | 401.96M | 423.02M | 463.10M |
Operating income | -98.87M | -120.69M | -121.35M | -128.12M |
Other non operating income | -48.00K | -4.69M | 1.55M | 308.00K |
EBT including unusual items | -92.59M | -130.22M | -111.70M | -119.96M |
EBT excluding unusual items | -92.47M | -116.52M | -111.70M | -118.96M |
Income tax expense | 136.00K | -1.73M | 372.00K | 185.00K |
Effective tax rate | -0.15% | 1.33% | -0.33% | -0.15% |
Other operating expenses | - | - | - | - |
Net income | -92.72M | -128.49M | -112.08M | -120.14M |
Net profit margin | -34.96% | -45.68% | -37.15% | -35.87% |
Earnings per share | -0.39 | -0.50 | -0.45 | -0.42 |
Interest and investment income | 7.39M | 10.03M | 11.15M | 10.20M |
Interest expense | -943.00K | -1.18M | -3.05M | -1.35M |
Net interest expenses | 6.45M | 8.85M | 8.10M | 8.85M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -89.47M | -110.64M | -111.91M | -118.56M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events